Loading clinical trials...
Loading clinical trials...
Phase II Study of Pazopanib Maintenance for SCLC
Conditions
Interventions
Pazopanib
Placebo
Locations
1
South Korea
Samsung Medical Center
Seoul, South Korea
Start Date
June 1, 2013
Primary Completion Date
February 1, 2017
Completion Date
December 1, 2017
Last Updated
December 9, 2019
NCT07486219
NCT06305754
NCT05098132
NCT06731413
NCT04585750
NCT04826341
Lead Sponsor
Samsung Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions